Indian Pharmas In Trend To Focus On Targeted Drugs
This article was originally published in PharmAsia News
Executive Summary
Indian pharmaceutical companies are joining what appears to be a global trend of pharmas to shift their emphases to specialized or targeted drugs rather than relying on blockbusters. Dr. Reddy's Laboratories, Wockhardt and Lupin Pharmaceuticals are, as are several multinational drug makers, increasingly focused on cancer molecules, monoclonal antibodies and vaccines. Part of the change has come about because of moves by generics makers into supplying medicines used in primary care. (Click here for more